Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $1.60 billion. The enterprise value is $3.02 billion.
| Market Cap | 1.60B |
| Enterprise Value | 3.02B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, after market close.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 36.25 million shares outstanding. The number of shares has decreased by -3.05% in one year.
| Shares Outstanding | 36.25M |
| Shares Change (YoY) | -3.05% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 93.52% |
| Float | 35.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.69 |
| PS Ratio | 0.93 |
| Forward PS | 1.06 |
| PB Ratio | 2.50 |
| P/FCF Ratio | 16.55 |
| PEG Ratio | 2.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.43, with an EV/FCF ratio of 31.64.
| EV / Earnings | n/a |
| EV / Sales | 1.78 |
| EV / EBITDA | 13.43 |
| EV / EBIT | 36.24 |
| EV / FCF | 31.64 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 2.43.
| Current Ratio | 1.82 |
| Quick Ratio | 0.77 |
| Debt / Equity | 2.43 |
| Debt / EBITDA | 6.83 |
| Debt / FCF | 16.10 |
| Interest Coverage | 0.89 |
Financial Efficiency
Return on equity (ROE) is -0.80%.
| Return on Equity (ROE) | -0.80% |
| Return on Assets (ROA) | -0.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $995,353 |
| Profits Per Employee | -$3,176 |
| Employee Count | 1,700 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 3.79 |
Taxes
| Income Tax | -4.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.55% in the last 52 weeks. The beta is 1.85, so Ingevity's price volatility has been higher than the market average.
| Beta (1Y) | 1.85 |
| 52-Week Price Change | -39.55% |
| 50-Day Moving Average | 46.06 |
| 200-Day Moving Average | 46.92 |
| Relative Strength Index (RSI) | 38.71 |
| Average Volume (30 Days) | 224,759 |
Short Selling Information
The latest short interest is 694,319, so 1.92% of the outstanding shares have been sold short.
| Short Interest | 694,319 |
| Short Previous Month | 809,818 |
| Short % of Shares Out | 1.92% |
| Short % of Float | 1.93% |
| Short Ratio (days to cover) | 3.19 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.69 billion and -$5.40 million in losses. Loss per share was -$0.15.
| Revenue | 1.69B |
| Gross Profit | 471.90M |
| Operating Income | 82.60M |
| Pretax Income | -10.10M |
| Net Income | -5.40M |
| EBITDA | 224.60M |
| EBIT | 83.20M |
| Loss Per Share | -$0.15 |
Balance Sheet
The company has $95.90 million in cash and $1.53 billion in debt, giving a net cash position of -$1.44 billion or -$39.69 per share.
| Cash & Cash Equivalents | 95.90M |
| Total Debt | 1.53B |
| Net Cash | -1.44B |
| Net Cash Per Share | -$39.69 |
| Equity / Book Value | 631.40M |
| Book Value Per Share | 17.42 |
| Working Capital | 295.70M |
Cash Flow
In the last 12 months, operating cash flow was $205.10 million and capital expenditures -$109.80 million, giving a free cash flow of $95.30 million.
| Operating Cash Flow | 205.10M |
| Capital Expenditures | -109.80M |
| Free Cash Flow | 95.30M |
| FCF Per Share | $2.63 |
Margins
Gross margin is 27.89%, with operating and profit margins of 4.88% and -0.32%.
| Gross Margin | 27.89% |
| Operating Margin | 4.88% |
| Pretax Margin | -0.60% |
| Profit Margin | -0.32% |
| EBITDA Margin | 13.27% |
| EBIT Margin | 4.92% |
| FCF Margin | 5.63% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.05% |
| Shareholder Yield | 3.05% |
| Earnings Yield | -0.34% |
| FCF Yield | 6.04% |
Analyst Forecast
The average price target for Ingevity is $48.67, which is 10.34% higher than the current price. The consensus rating is "Hold".
| Price Target | $48.67 |
| Price Target Difference | 10.34% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 1.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.89 |
| Piotroski F-Score | 4 |